1. Booz, G.W. Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative
    stress (2011) Free Radical Biology and Medicine, 51 (5), pp. 1054-1061.
  2. Sagredo, O., Pazos, M.R., Satta, V., Ramos, J.A., Pertwee, R.G., Fernández-Ruiz, J. Neuroprotective effects of
    phytocannabinoid-based medicines in experimental models of Huntington's disease (2011) Journal of Neuroscience
    Research, 89 (9), pp. 1509-1518.
  3. Carter, G.T., Flanagan, A.M., Earleywine, M., Abrams, D.I., Aggarwal, S.K., Grinspoon, L. Cannabis in palliative
    medicine: Improving care and reducing opioid-related morbidity (2011) American Journal of Hospice and Palliative
    Medicine, 28 (5), pp. 297-303.
  4. Gonzalez, R., Schuster, R.M., Vassileva, J., Martin, E.M. Impact of HIV and a history of marijuana dependence on
    procedural learning among individuals with a history of substance dependence (2011) Journal of Clinical and
    Experimental Neuropsychology, 33 (7), pp. 735-752.
  5. Alonso-Alconada, D., Alvarez, A., Hilario, E. Cannabinoid as a neuroprotective strategy in perinatal hypoxic-
    ischemic injury (2011) Neuroscience Bulletin, 27 (4), pp. 275-285. Cited 1 time.
  6. Cunha, P., Romão, A.M., Mascarenhas-Melo, F., Teixeira, H.M., Reis, F. Endocannabinoid system in
    cardiovascular disorders-new pharmacotherapeutic opportunities (2011) Journal of Pharmacy and Bioallied
    Sciences, 3 (3), pp. 350-360.
  7. Schweinsburg, A.D., Schweinsburg, B.C., Nagel, B.J., Eyler, L.T., Tapert, S.F. Neural correlates of verbal learning
    in adolescent alcohol and marijuana users(2011) Addiction, 106 (3), pp. 564-573. Cited 1 time.
  8. Zoppi, S., Pérez Nievas, B.G., Madrigal, J.L.M., Manzanares, J., Leza, J.C., García-Bueno, B.Regulatory role of
    cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation (2011) Neuropsychopharmacology,
    36 (4), pp. 805-818. Cited 2 times.
  9. Alves, F.H.F., Crestani, C.C., Gomes, F.V., Guimarães, F.S., Correa, F.M.A., Resstel, L.B.M.Cannabidiol
    injected into the bed nucleus of the stria terminalis modulates baroreflex activity through 5-HT1A receptors (2010)
    Pharmacological Research, 62 (3), pp. 228-236. Cited 6 times.
  10. Hayakawa, K., Mishima, K., Fujiwara, M.Therapeutic potential of non-psychotropic cannabidiol in ischemic stroke
    (2010) Pharmaceuticals, 3 (7), pp. 2197-2212.
  11. Carter, G.T., Abood, M.E., Aggarwal, S.K., Weiss, M.D.Cannabis and amyotrophic lateral sclerosis: Hypothetical
    and practical applications, and a call for clinical trials(2010) American Journal of Hospice and Palliative Medicine,
    27 (5), pp. 347-356. Cited 1 time.
  12. Khan, R.U., Durrani, F.R., Chand, N., Anwar, H. Influence of feed supplementation with cannabis sativa on quality
    of broilers carcass (2010) Pakistan Veterinary Journal, 30 (1), pp. 34-38. Cited 1 time.
  13. Jacobus, J., McQueeny, T., Bava, S., Schweinsburg, B.C., Frank, L.R., Yang, T.T., Tapert, S.F. White matter
    integrity in adolescents with histories of marijuana use and binge drinking (2009) Neurotoxicology and Teratology,
    31 (6), pp. 349-355. Cited 17 times.
  14. Schneider, M. Cannabis use in pregnancy and early life and its consequences: Animal models (2009) European
    Archives of Psychiatry and Clinical Neuroscience, 259 (7), pp. 383-393. Cited 12 times.
  15. Hayakawa, K., Irie, K., Sano, K., Watanabe, T., Higuchi, S., Enoki, M., Nakano, T., Harada, K., Ishikane, S.,
    Ikeda, T., Fujioka, M., Orito, K., Iwasaki, K., Mishima, K., Fujiwara, M. Therapeutic time window of cannabidiol
    treatment on delayed ischemic damage via high-mobility group box1-inhibiting mechanism (2009) Biological and
    Pharmaceutical Bulletin, 32 (9), pp. 1538-1544. Cited 3 times.
  16. Schnell, T., Koethe, D., Daumann, J., Gouzoulis-Mayfrank, E. The role of cannabis in cognitive functioning of
    patients with schizophrenia (2009) Psychopharmacology, 205 (1), pp. 45-52. Cited 11 times.
  17. Kreutz, S., Koch, M., Böttger, C., Ghadban, C., Korf, H.-W., Dehghani, F. 2-arachidonoylglycerol elicits
    neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive
    receptors on microglial cells (2009) GLIA, 57 (3), pp. 286-294. Cited 14 times.
  18. Iuvone, T., Esposito, G., De Filippis, D., Scuderi, C., Steardo, L. Cannabidiol: A promising drug for
    neurodegenerative disorders? (2009) CNS Neuroscience and Therapeutics, 15 (1), pp. 65-75. Cited 20 times.
  19. Kayakawa, K., Mishima, K., Irie, K., Hazekawa, M., Mishima, S., Fujioka, M., Orito, K., Egashira, N.,
    Katsurabayashi, S., Takasaki, K., Iwasaki, K., Fujiwara, M. Cannabidiol prevents a post-ischemic injury
    progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism (2008)
    Neuropharmacology, 55 (8), pp. 1280-1286. Cited 13 times.
  20. E Silva, T.B., Pereira, M.A., Malta, V.S., Bento, E.S., San-Miguel, M.A., Ziolli, R.L., Martins, J.B.L., Sih, A.,
    Taft, C.A. Study of the structure-activity relationship for theoretical molecular descriptors using density functional
    theory and chemometric methods in cannabinoid metabolites (2008) International Journal of Quantum Chemistry,
    108 (13), pp. 2530-2539. Cited 2 times.
  21. Ahmed, S.A., Ross, S.A., Slade, D., Radwan, M.M., Khan, I.A., ElSohly, M.A.Structure determination and
    absolute configuration of cannabichromanone derivatives from high potency Cannabis sativa (2008) Tetrahedron
    Letters, 49 (42), pp. 6050-6053. Cited 9 times.
  22. Schilt, T., De Win, M.M.L., Jager, G., Koeter, M.W., Ramsey, N.F., Schmand, B., Van Den Brink, W. Specific
    effects of ecstasy and other illicit drugs on cognition in poly-substance users (2008) Psychological Medicine, 38 (9),
    pp. 1309-1317. Cited 15 times.
  23. Caffarel, M.M., Moreno-Bueno, G., Cerutti, C., Palacios, J., Guzman, M., Mechta-Grigoriou, F., Sanchez, C.
    JunD is involved in the antiproliferative effect of Δ9- tetrahydrocannabinol on human breast cancer cells (2008)
    Oncogene, 27 (37), pp. 5033-5044. Cited 9 times.
  24. Pushkarev, V.M., Kovzun, O.I., Tronko, M.D. Antineoplastic and apoptotic effects of cannabinoids. N-
    acylethanolamines: Protectors or killers? (2008) Experimental Oncology, 30 (1), pp. 6-21. Cited 3 times.
  25. Carter, G.T., Weiss, M.D., Han, J.J., Chance, P.F., England, J.D. Charcot-Marie-Tooth disease (2008) Current
    Treatment Options in Neurology, 10 (2), pp. 94-102. Cited 4 times.
  26. Wu, H.-Y., Chu, R.-M., Wang, C.-C., Lee, C.-Y., Lin, S.-H., Jan, T.-R. Cannabidiol-induced apoptosis in
    primary lymphocytes is associated with oxidative stress-dependent activation of caspase-8 (2008) Toxicology and
    Applied Pharmacology, 226 (3), pp. 260-270. Cited 11 times.
  27. Pacher, P., Haskó, G. Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and
    preconditioning (2008) British Journal of Pharmacology, 153 (2), pp. 252-262. Cited 63 times.
  28. Dowling, G.J., Weiss, S.R.B., Condon, T.P. Drugs of abuse and the aging brain (2008)
    Neuropsychopharmacology, 33 (2), pp. 209-218. Cited 21 times.
  29. Zani, A., Braida, D., Capurro, V., Sala, M. Δ9-Tetrahydrocannabinol (THC) and AM 404 protect against cerebral
    ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors (2007) British Journal of
    Pharmacology, 152 (8), pp. 1301-1311. Cited 15 times.
  30. Hayakawa, K., Mishima, K., Nozako, M., Hazekawa, M., Irie, K., Fujioka, M., Orito, K., Abe, K., Hasebe, N.,
    Egashira, N., Iwasaki, K., Fujiwara, M. Delayed treatment with cannabidiol has a cerebroprotective action via a
    cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism (2007) Journal of Neurochemistry, 102
    (5), pp. 1488-1496. Cited 17 times.


Gonzalez, R.
Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance
(2007) Neuropsychology Review, 17 (3), pp. 347-361. Cited 21 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
34848914850&partnerID=40&md5=af6c28dc4a8bc93b48e436c52bfc885c
DOCUMENT TYPE: Review
SOURCE: Scopus

Dagon, Y., Avraham, Y., Link, G., Zolotarev, O., Mechoulam, R., Berry, E.M.
The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice and hyperglycemic pheochromocytoma
PC12 cells
(2007) Neurobiology of Disease, 27 (2), pp. 174-181. Cited 7 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
34447632664&partnerID=40&md5=7fe8cc712685df1dd5e95e692973a467
DOCUMENT TYPE: Article
SOURCE: Scopus

Parrott, A.C., Milani, R.M., Gouzoulis-Mayfrank, E., Daumann, J.
Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): An analysis of their neuropsychobiological
interactions in recreational users
(2007) Journal of Neural Transmission, 114 (8), pp. 959-968. Cited 22 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
34547117589&partnerID=40&md5=5a32779769fbc826ac9bd9fd08359f74
DOCUMENT TYPE: Review
SOURCE: Scopus

Sagredo, O., Ramos, J.A., Decio, A., Mechoulam, R., Fernández-Ruiz, J.
Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation
of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors
(2007) European Journal of Neuroscience, 26 (4), pp. 843-851. Cited 31 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
34547984234&partnerID=40&md5=9db8fe5174e7a6c03901311f1d6b7037
DOCUMENT TYPE: Article
SOURCE: Scopus

Esposito, G., Scuderi, C., Savani, C., Steardo Jr., L., De Filippis, D., Cottone, P., Iuvone, T., Cuomo, V., Steardo, L.
Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression
(2007) British Journal of Pharmacology, 151 (8), pp. 1272-1279. Cited 34 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
34547878297&partnerID=40&md5=8e59e9757e875445008e2accf7d42de5
DOCUMENT TYPE: Article
SOURCE: Scopus

Jager, G., De Win, M.M., Vervaeke, H.K., Schilt, T., Kahn, R.S., Van Den Brink, W., Van Ree, J.M., Ramsey, N.F.
Incidental use of ecstasy: No evidence for harmful effects on cognitive brain function in a prospective fMRI study
(2007) Psychopharmacology, 193 (3), pp. 403-414. Cited 16 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
34447321603&partnerID=40&md5=818a10c6a93e885f372bb9d72d5c2c17
DOCUMENT TYPE: Article
SOURCE: Scopus

Hayakawa, K., Mishima, K., Nozako, M., Ogata, A., Hazekawa, M., Liu, A.-X., Fujioka, M., Abe, K., Hasebe, N.,
Egashira, N., Iwasaki, K., Fujiwara, M.
Repeated treatment with cannabidiol but not Δ9-tetrahydrocannabinol has a neuroprotective effect without the development
of tolerance
(2007) Neuropharmacology, 52 (4), pp. 1079-1087. Cited 18 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
33847261953&partnerID=40&md5=864b4af72200524012ab20dec10dc5a6
DOCUMENT TYPE: Article
SOURCE: Scopus

García-Arencibia, M., González, S., de Lago, E., Ramos, J.A., Mechoulam, R., Fernández-Ruiz, J.
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant
and cannabinoid receptor-independent properties
(2007) Brain Research, 1134 (1), pp. 162-170. Cited 55 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
33846401540&partnerID=40&md5=d27d1e544a248e255d675c6b01f5d82d
DOCUMENT TYPE: Article
SOURCE: Scopus

da Silva, A.A., Bester, M.J., Pretorius, E.
Effects of Mandrax and Cannabis on the cellular function of chick embryonic neurons
(2007) Environmental Toxicology and Pharmacology, 23 (1), pp. 82-88. Cited 1 time.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
33845210946&partnerID=40&md5=8ccf269ea0c7f20421258b6cbac78cb8
DOCUMENT TYPE: Article
SOURCE: Scopus

Ullrich, O., Schneider-Stock, R., Zipp, F.
Cell-cell communication by endocannabinoids during immune surveillance of the central nervous system
(2006) Results and Problems in Cell Differentiation, 43, pp. 281-305. Cited 8 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
33749064638&partnerID=40&md5=f0df266560f03c40ae961334ab7edc47
DOCUMENT TYPE: Article
SOURCE: Scopus

Bonfils, P.K., Reith, J., Hasseldam, H., Johansen, F.F.
Estimation of the hypothermic component in neuroprotection provided by cannabinoids following cerebral ischemia
(2006) Neurochemistry International, 49 (5), pp. 508-518. Cited 13 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
33746899346&partnerID=40&md5=b43f0d34e75dcb2ac8035093b15099f4
DOCUMENT TYPE: Article
SOURCE: Scopus

Pacher, P., Bátkai, S., Kunos, G.
The endocannabinoid system as an emerging target of pharmacotherapy
(2006) Pharmacological Reviews, 58 (3), pp. 389-462. Cited 502 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
33748703859&partnerID=40&md5=8c795af94fc4d9e4dc984a5a238cd5a4
DOCUMENT TYPE: Review
SOURCE: Scopus

Varvel, S.A., Wiley, J.L., Yang, R., Bridgen, D.T., Long, K., Lichtman, A.H., Martin, B.R.
Interactions between THC and cannabidiol in mouse models of cannabinoid activity
(2006) Psychopharmacology, 186 (2), pp. 226-234. Cited 20 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
33646558622&partnerID=40&md5=18dbc45bdd1b2d5d728f0e428ae35536
DOCUMENT TYPE: Article
SOURCE: Scopus

Zhu, H.-J., Wang, J.-S., Markowitz, J.S., Donovan, J.L., Gibson, B.B., Gefroh, H.A., DeVane, C.L.
Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana
(2006) Journal of Pharmacology and Experimental Therapeutics, 317 (2), pp. 850-857. Cited 27 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
33645841349&partnerID=40&md5=15b39faa56c454c4b43805e68705e00e
DOCUMENT TYPE: Article
SOURCE: Scopus

Russo, E., Guy, G.W.
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
(2005) Medical Hypotheses, 66 (2), pp. 234-246. Cited 84 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
28844489930&partnerID=40&md5=cebd20241a4153c8d7d2cab695336e9b
DOCUMENT TYPE: Review
SOURCE: Scopus

Long, L.E., Malone, D.T., Taylor, D.A.
The pharmacological actions of cannabidiol
(2005) Drugs of the Future, 30 (7), pp. 747-753. Cited 9 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
27644501103&partnerID=40&md5=5dfaf4e5acd0a9537d256e62fa8f1669
DOCUMENT TYPE: Review
SOURCE: Scopus

Teatre, L., Zajicek, J.
The use of cannabinoids in multiple sclerosis
(2005) Expert Opinion on Investigational Drugs, 14 (7), pp. 859-869. Cited 4 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
22744435191&partnerID=40&md5=bff1d5ea05d39b6ae385c1d800ecfdca
DOCUMENT TYPE: Review
SOURCE: Scopus

Milani, R.M., Parrott, A.C., Schifano, F., Turner, J.J.D.
Pattern of cannabis use in ecstasy polydrug users: Moderate cannabis use may compensate for self-rated aggression and
somatic symptoms
(2005) Human Psychopharmacology, 20 (4), pp. 249-261. Cited 17 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
21044438319&partnerID=40&md5=7c37cb7483dadc8efb25e1ffae0d0c13
DOCUMENT TYPE: Article
SOURCE: Scopus

Kovacic, P.
Unifying mechanism for addiction and toxicity of abused drugs with application to dopamine and glutamate mediators:
Electron transfer and reactive oxygen species
(2005) Medical Hypotheses, 65 (1), pp. 90-96. Cited 17 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
18944381277&partnerID=40&md5=693da8c912f68ae86ef4e2632df952d4
DOCUMENT TYPE: Article
SOURCE: Scopus

Zhuang, S.-Y., Bridges, D., Grigorenko, E., McCloud, S., Boon, A., Hampson, R.E., Deadwyler, S.A.
Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores
(2005) Neuropharmacology, 48 (8 SPEC. ISS.), pp. 1086-1096. Cited 41 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
19444373244&partnerID=40&md5=e42b0df71f0b6528acf88d4454676a41
DOCUMENT TYPE: Article
SOURCE: Scopus

Lastres-Becker, I., Molina-Holgado, F., Ramos, J.A., Mechoulam, R., Fernández-Ruiz, J.
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's
disease
(2005) Neurobiology of Disease, 19 (1-2), pp. 96-107. Cited 105 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
17444370570&partnerID=40&md5=65842fe9087e49646aeb2ebb910add3f
DOCUMENT TYPE: Article
SOURCE: Scopus

Pryce, G., Baker, D.
Emerging properties of cannabinoid medicines in management of multiple sclerosis
(2005) Trends in Neurosciences, 28 (5), pp. 272-276. Cited 37 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
21744442759&partnerID=40&md5=014dcdb7d5cb579ad15a00a87d47af0e
DOCUMENT TYPE: Review
SOURCE: Scopus

Mishima, K., Hayakawa, K., Abe, K., Ikeda, T., Egashira, N., Iwasaki, K., Fujiwara, M.
Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism
(2005) Stroke, 36 (5), pp. 1071-1076. Cited 41 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
18244396915&partnerID=40&md5=db4e58e48791ae5450d08a89e737297f
DOCUMENT TYPE: Article
SOURCE: Scopus

Chen, J., Lee, C.-T., Errico, S., Deng, X., Cadet, J.L., Freed, W.J.
Protective effects of Δ9-tetrahydrocannabinol against N-methyl-D-aspartate-induced AF5 cell death
(2005) Molecular Brain Research, 134 (2), pp. 215-225. Cited 16 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
17044368725&partnerID=40&md5=c69f3989649092fa170c242869461e0c
DOCUMENT TYPE: Article
SOURCE: Scopus

Parrott, A.C., Gouzoulis-Meyfrank, E., Rodgers, J., Solowij, N.
Ecstasy/MDMA and cannabis: The complexities of their interactive neuropsychobiological effects
(2004) Journal of Psychopharmacology, 18 (4), pp. 572-575. Cited 17 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
10844239136&partnerID=40&md5=8858b5a3aa75ecbb1c96a686b303f960
DOCUMENT TYPE: Conference Paper
SOURCE: Scopus

Gonzalez, R., Rippeth, J.D., Carey, C.L., Heaton, R.K., Moore, D.J., Schweinsburg, B.C., Cherner, M., Grant, I.
Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure
(2004) Drug and Alcohol Dependence, 76 (2), pp. 181-190. Cited 44 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
5644271850&partnerID=40&md5=37152c4bf87b7fbb0dcbb6bbad92b552
DOCUMENT TYPE: Article
SOURCE: Scopus

Carter, G.T., Ugalde, V.
Medical marijuana: Emerging applications for the management of neurologic disorders
(2004) Physical Medicine and Rehabilitation Clinics of North America, 15 (4), pp. 943-954. Cited 8 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
5344255281&partnerID=40&md5=34d0522310d72b23c25ce53e4755b3ad
DOCUMENT TYPE: Review
SOURCE: Scopus

Hayakawa, K., Mishima, K., Abe, K., Hasebe, N., Takamatsu, F., Yasuda, H., Ikeda, T., Inui, K., Egashira, N., Iwasaki,
K., Fujiwara, M.
Cannabidiol prevents infarction via the non-CBI cannabinoid receptor mechanism
(2004) NeuroReport, 15 (15), pp. 2381-2385. Cited 33 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
8444238592&partnerID=40&md5=ac92f6fd184bf79350d3017bff368b3c
DOCUMENT TYPE: Article
SOURCE: Scopus

Jüttler, E., Potrovita, I., Tarabin, V., Prinz, S., Dong-Si, T., Fink, G., Schwaninger, M.
The cannabinoid dexanabinol is an inhibitor of the nuclear factor-kappa B (NF-κB)
(2004) Neuropharmacology, 47 (4), pp. 580-592. Cited 19 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
4544378328&partnerID=40&md5=cdd9cb24d6fc199de919166167c13067
DOCUMENT TYPE: Article
SOURCE: Scopus

Baker, D., Pryce, G.
The potential role of the endocannabinoid system in the control of multiple scleorsis
(2004) Current Medicinal Chemistry - Central Nervous System Agents, 4 (3), pp. 195-202. Cited 3 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
4043155636&partnerID=40&md5=e9019f9e2880cb663b48f42e9627d5eb
DOCUMENT TYPE: Review
SOURCE: Scopus

Biegon, A.
Cannabinoids as neuroprotective agents in traumatic brain injury
(2004) Current Pharmaceutical Design, 10 (18), pp. 2177-2183. Cited 16 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
3042545191&partnerID=40&md5=b8a7d6bc8aa6d1f414651308048ef980
DOCUMENT TYPE: Review
SOURCE: Scopus

McQueen, D.S., Bond, S.M., Smith, P.J.W., Balali-Mood, K., Smart, D.
Cannabidiol lacks the vanilloid VR1-mediated vasorespiratory effects of capsaicin and anandamide in anaesthetised rats
(2004) European Journal of Pharmacology, 491 (2-3), pp. 181-189. Cited 12 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
2342624534&partnerID=40&md5=9bb8275ae61716f37c5856d1e9d26dba
DOCUMENT TYPE: Article
SOURCE: Scopus

Tomida, I., Perlwee, R.G., Azuara-Blanco, A.
Cannabinoids and glaucoma
(2004) British Journal of Ophthalmology, 88 (5), pp. 708-713. Cited 42 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
1942517916&partnerID=40&md5=359890fbf31ea135c92194b7474b0815
DOCUMENT TYPE: Review
SOURCE: Scopus

Iuvone, T., Esposito, G., Esposito, R., Santamaria, R., Di Rosa, M., Izzo, A.A.
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on β-amyloid-induced toxicity
in PC12 cells
(2004) Journal of Neurochemistry, 89 (1), pp. 134-141. Cited 89 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
1842510018&partnerID=40&md5=a4dfa9fa4ca9380e7c81663baaefa08d
DOCUMENT TYPE: Article
SOURCE: Scopus

Massi, P., Vaccani, A., Ceruti, S., Colombo, A., Abbracchio, M.P., Parolaro, D.
Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines
(2004) Journal of Pharmacology and Experimental Therapeutics, 308 (3), pp. 838-845. Cited 54 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
1342280974&partnerID=40&md5=abc6414008a03b7620ab54ebf84e5052
DOCUMENT TYPE: Article
SOURCE: Scopus

Amtmann, D., Weydt, P., Johnson, K.L., Jensen, M.P., Carter, G.T.
Survey of cannabis use in patients with amyotrophic lateral sclerosis
(2004) American Journal of Hospice and Palliative Medicine, 21 (2), pp. 95-104. Cited 23 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
2342430778&partnerID=40&md5=469cdd410ebe68645c9c70e9396aba43
DOCUMENT TYPE: Review
SOURCE: Scopus

Pertwee, R.G.
Pharmacological and therapeutic targets for Δ9- tetrahydrocannabinol and cannabidiol
(2004) Euphytica, 140 (1-2), pp. 73-82. Cited 11 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
16444368192&partnerID=40&md5=cec57c0952411331fa96d36a8b39286b
DOCUMENT TYPE: Conference Paper
SOURCE: Scopus

Callaway, J.C.
Hempseed as a nutritional resource: An overview
(2004) Euphytica, 140 (1-2), pp. 65-72. Cited 33 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
16444384740&partnerID=40&md5=ed7713415485a7532b3dcd117b6b83b0
DOCUMENT TYPE: Conference Paper
SOURCE: Scopus

Platt, B., Drysdale, A.J.
Search and rescue: Identification of cannabinoid actions relevant for a neuronal survival and protection
(2004) Current Neuropharmacology, 2 (1), pp. 103-114. Cited 2 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
3042511470&partnerID=40&md5=fe9fbaef88454d95cec27d6803e08f4a
DOCUMENT TYPE: Review
SOURCE: Scopus

Jacintho, J.D., Kovacic, P.
Neurotransmission and neurotoxicity by nitric oxide, catecholamines, and Glutamate: Unifying themes of reactive oxygen
species and electron transfer
(2003) Current Medicinal Chemistry, 10 (24), pp. 2693-2703. Cited 27 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
0345255903&partnerID=40&md5=12d47c528440c2a9d6e7115e13c3e7d5
DOCUMENT TYPE: Review
SOURCE: Scopus

Mauler, F., Horváth, E., De Vry, J., Jäger, R., Schwarz, T., Sandmann, S., Weinz, C., Heinig, R., Böttcher, M.
BAY 38-7271: A Novel Highly Selective and Highly Potent Cannabinoid Receptor Agonist for the Treatment of Traumatic
Brain Injury
(2003) CNS Drug Reviews, 9 (4), pp. 343-358. Cited 18 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
0348049459&partnerID=40&md5=60f2a4def057c2e0be350d6042f851ba
DOCUMENT TYPE: Review
SOURCE: Scopus

Leker, R.R., Gai, N., Mechoulam, R., Ovadia, H.
Drug-induced hypothermia reduces ischemic damage: Effects of the cannabinoid HU-210
(2003) Stroke, 34 (8), pp. 2000-2006. Cited 57 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
0041621495&partnerID=40&md5=156cd475ccc67f5a2d280c24e56903ac
DOCUMENT TYPE: Article
SOURCE: Scopus

Braida, D., Pegorini, S., Arcidiacono, M.V., Consalez, G.G., Croci, L., Sala, M.
Post-ischemic treatment with cannabidiol prevents electroencephalographic flattening, hyperlocomotion and neuronal injury
in gerbils
(2003) Neuroscience Letters, 346 (1-2), pp. 61-64. Cited 29 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
0037707636&partnerID=40&md5=212b631e0b483274526125430657167b
DOCUMENT TYPE: Article
SOURCE: Scopus

Baker, D., Pryce, G., Giovannoni, G., Thompson, A.J.
The therapeutic potential of cannabis
(2003) Lancet Neurology, 2 (5), pp. 291-298. Cited 156 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
0041534429&partnerID=40&md5=c28c1114284ef67f223d8a9ea3b15d04
DOCUMENT TYPE: Review
SOURCE: Scopus

Pacini, M., Maremmani, I.
Terapeutic properties of cannabinoids: State-of-the-art and research perspectives [Proprietà terapeutiche dei cannabinoidi:
Stato dell'arte e implicazioni per la ricerca]
(2003) Italian Journal of Psychopathology, 9 (1), pp. 58-70.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
0037335737&partnerID=40&md5=f974b501e3b9cedea0da655ebc36c2e1
DOCUMENT TYPE: Review
SOURCE: Scopus

Carter, G.T., Krivickas, L.S., Weydt, P., Weiss, M.D., Miller, R.G.
Drug therapy for amyotrophic lateral sclerosis: Where are we now?
(2003) IDrugs, 6 (2), pp. 147-153. Cited 11 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
0037293061&partnerID=40&md5=814e7a8c7016b740e75ad52f39b0eedc
DOCUMENT TYPE: Review
SOURCE: Scopus

Lorenz, R.
Spastic and myocloni in a childhood neurodegenerative disease - New therapeutic options
(2002) Neuroendocrinology Letters, 23 (5-6), pp. 387-390. Cited 2 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
0036781646&partnerID=40&md5=cc3dd156ee1ca1fe7e99ee62e1b4c0d7
DOCUMENT TYPE: Article
SOURCE: Scopus

Kimura, M., Masuda, T., Yamada, K., Kubota, N., Kawakatsu, N., Mitani, M., Kishii, K., Inazu, M., Namiki, T.
Novel diphenylalkyl piperazine derivatives with dual calcium antagonistic and antioxidative activities
(2002) Bioorganic and Medicinal Chemistry Letters, 12 (15), pp. 1947-1950. Cited 9 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
0037025443&partnerID=40&md5=56dff2bbea416ad210b121b4854797c7
DOCUMENT TYPE: Article
SOURCE: Scopus

Mauler, F., Mittendorf, J., Horváth, E., De Vry, J.
Characterization of the diarylether sulfonylester (-)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-
suifonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties
(2002) Journal of Pharmacology and Experimental Therapeutics, 302 (1), pp. 359-368. Cited 50 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
0036082491&partnerID=40&md5=66e19c1ac915d18e2f64ebdbaa8ed784
DOCUMENT TYPE: Article
SOURCE: Scopus

Downer, E., Boland, B., Fogarty, M., Campbell, V.
Δ9-Tetrahydrocannabinol induces the apoptotic pathway in cultured cortical neurones via activation of the CB1 receptor
(2001) NeuroReport, 12 (18), pp. 3973-3978. Cited 34 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
0035930446&partnerID=40&md5=1383ff8291f3979d821f4585f58f21db
DOCUMENT TYPE: Article
SOURCE: Scopus

Kirkham, T.C., Williams, C.M.
Endogenous cannabinoids and appetite
(2001) Nutrition Research Reviews, 14 (1), pp. 65-86. Cited 92 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
0034972990&partnerID=40&md5=21d07b799d2ae4839900c6da8204b669
DOCUMENT TYPE: Review
SOURCE: Scopus

Di Marzo, V., Bisogno, T., Petrocellis, L.D.
Endocannabinoids Part II: Pathological CNS conditions involving the endocannabinoid system and their possible treatment
with endocannabinoid-based drugs
(2001) Expert Opinion on Therapeutic Targets, 5 (3), pp. 349-362. Cited 4 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
0000479335&partnerID=40&md5=6865a8fbc15581ec4c08d6b4f2a1e207
DOCUMENT TYPE: Review
SOURCE: Scopus

Campbell, V.A.
Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome c release and
caspase-3 activation
(2001) Neuropharmacology, 40 (5), pp. 702-709. Cited 45 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
0035049233&partnerID=40&md5=7cd7c9dd29455de1f4f9cc7196c27e3e
DOCUMENT TYPE: Article
SOURCE: Scopus

Contestabile, A.
Antioxidant strategies for neurodegenerative diseases
(2001) Expert Opinion on Therapeutic Patents, 11 (4), pp. 573-585. Cited 7 times.
http://www.scopus.com/inward/record.url?eid=2-s2.0-
0035060223&partnerID=40&md5=7255d7c33e45bbc911ba291f8e21c4aa
DOCUMENT TYPE: Review
SOURCE: Scopus




  5. Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress Author
    (s): Booz George W. Source: FREE RADICAL BIOLOGY AND MEDICINE Volume: 51 Issue: 5 Special Issue:
    SI Pages: 1054-1061 DOI: 10.1016/j.freeradbiomed.2011.01.007 Published: SEP 1 2011 Times Cited: 1 (from All
    Databases)
  6. Cannabis in Palliative Medicine: Improving Care and Reducing Opioid-Related Morbidity Author(s): Carter Gregory
    T.; Flanagan Aaron M.; Earleywine Mitchell; et al. Source: AMERICAN JOURNAL OF HOSPICE &
    PALLIATIVE MEDICINE Volume: 28 Issue: 5 Pages: 297-303 DOI: 10.1177/1049909111402318 Published:
    AUG 2011 Times Cited: 0 (from All Databases)  
  7. Neuroprotective Effects of Phytocannabinoid-Based Medicines in Experimental Models of Huntington's Disease
    Author(s): Sagredo Onintza; Pazos M. Ruth; Satta Valentina; et al. Source: JOURNAL OF NEUROSCIENCE
    RESEARCH Volume: 89 Issue: 9 Pages: 1509-1518 DOI: 10.1002/jnr.22682 Published: SEP 2011
  8. Neural correlates of verbal learning in adolescent alcohol and marijuana users Author(s): Schweinsburg AD,
    Schweinsburg BC, Nagel BJ, et al. Source: ADDICTION Volume: 106 Issue: 3 Pages: 564-573 Published: MAR
    2011
  9. Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation Author(s):
    Zoppi S, Nievas BGP, Madrigal JLM, et al. Source: NEUROPSYCHOPHARMACOLOGY Volume: 36 Issue: 4
    Pages: 805-818 Published: MAR 2011
  10. Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and Practical Applications, and a Call for Clinical Trials
    Author(s): Carter GT, Abood ME, Aggarwal SK, et al. Source: AMERICAN JOURNAL OF HOSPICE &
    PALLIATIVE MEDICINE Volume: 27 Issue: 5 Pages: 347-356 Published: AUG 2010
  11. Cannabidiol injected into the bed nucleus of the stria terminalis modulates baroreflex activity through 5-HT1A
    receptors Author(s): Alves FHF, Crestani CC, Gomes FV, et al. Source: PHARMACOLOGICAL RESEARCH
    Volume: 62 Issue: 3 Pages: 228-236
  12. Influence of Feed Supplementation with Cannabis Sativa on Quality of Broilers Carcass Author(s): Khan RU,
    Durrani FR, Chand N, et al. Source: PAKISTAN VETERINARY JOURNAL Volume: 30 Issue: 1 Pages: 34-38
  13. White matter integrity in adolescents with histories of marijuana use and binge drinking Author(s): Jacobus J,
    McQueeny T, Bava S, et al. Source: NEUROTOXICOLOGY AND TERATOLOGY Volume: 31 Issue: 6 Pages:
    349-355 Published: NOV-DEC 2009
  14. Cannabis use in pregnancy and early life and its consequences: animal models Author(s): Schneider M Source:
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE Volume: 259 Issue: 7
    Pages: 383-393 Published: OCT 2009
  15. Therapeutic Time Window of Cannabidiol Treatment on Delayed Ischemic Damage via High-Mobility Group Box1-
    Inhibiting Mechanism Author(s): Hayakawa K, Irie K, Sano K, et al. Source: BIOLOGICAL &
    PHARMACEUTICAL BULLETIN Volume: 32 Issue: 9 Pages: 1538-1544 Published: SEP 2009
  16. The role of cannabis in cognitive functioning of patients with schizophrenia Author(s): Schnell T, Koethe D, Daumann
    J, et al. Source: PSYCHOPHARMACOLOGY Volume: 205 Issue: 1 Pages: 45-52 Published: JUL 2009
  17. Cannabidiol: A Promising Drug for Neurodegenerative Disorders ? Author(s): Iuvone T, Esposito G, De Filippis D,
    et al. Source: CNS NEUROSCIENCE & THERAPEUTICS Volume: 15 Issue: 1 Pages: 65-75 Published: 2009
  18. Diabetic Retinopathy: Current Management and Experimental Therapeutic Targets Author(s): Ali TK, El-Remessy
    AB Source: PHARMACOTHERAPY Volume: 29 Issue: 2 Pages: 182-192 Published: FEB 2009
  19. 2-Arachidonoylglycerol Elicits Neuroprotective Effects on Excitotoxically Lesioned Dentate Gyrus Granule Cells via
    Abnormal-Cannabidiol-Sensitive Receptors on Microglial Cells Author(s): Kreutz S, Koch M, Bottger C, et al.
    Source: GLIA Volume: 57 Issue: 3 Pages: 286-294 Published: FEB 2009
  20. Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group
    box1-inhibiting mechanism Author(s): Hayakawa K, Mishima K, Irie K, et al. Source:
    NEUROPHARMACOLOGY Volume: 55 Issue: 8 Pages: 1280-1286 Published: DEC 2008
  21. Study of the structure-activity relationship for theoretical molecular descriptors using density functional theory and
    chemometric methods in cannabinoid metabolites Author(s): Silva TBE, Pereira MA, Malta VS, et al. Source:
    INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY Volume: 108 Issue: 13 Special Issue: Sp. Iss. SI
    Pages: 2530-2539 Published: NOV 5 2008
  22. Structure determination and absolute configuration of cannabichromanone derivatives from high potency Cannabis
    sativa Author(s): Ahmed SA, Ross SA, Slade D, et al. Source: TETRAHEDRON LETTERS Volume: 49 Issue: 42
    Pages: 6050-6053 Published: OCT 13 2008
  23. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users Author(s): Schilt T, de Win
    MML, Jager G, et al.Source: PSYCHOLOGICAL MEDICINE   Volume: 38   Issue: 9   Pages: 1309-1317   
    Published: SEP 2008
  24. Charcot-Marie-Tooth disease  Author(s): Carter GT, Weiss MD, Han JJ, et al. Source: CURRENT TREATMENT
    OPTIONS IN NEUROLOGY   Volume: 10   Issue: 2   Pages: 94-102   Published: MAR 2008
  25. JunD is involved in the antiproliferative effect of Delta(9)-tetrahydrocannabinol on human breast cancer cells Author
    (s): Caffarel MM, Moreno-Bueno G, Cerutti C, et al. Source: ONCOGENE Volume: 27 Issue: 37 Pages: 5033-
    5044 Published: AUG 28 2008
  26. Wu HY, Chu RM, Wang CC, et al. Cannabidiol-induced apoptosis in primary lymphocytes is associated with
    oxidative stress-dependent activation of caspase-8 TOXICOLOGY AND APPLIED PHARMACOLOGY
    Volume: 226 Issue: 3 Pages: 260-270
  27. Pacher P, Hasko G Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and
    preconditioning BRITISH JOURNAL OF PHARMACOLOGY Volume: 153 Issue: 2 Pages: 252-262
  28. Zani A, Braida D, Capurro V, et al. Delta(9)-Tetrahydrocannabinol (THC) and AM 404 protect against cerebral
    ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors BRITISH JOURNAL OF
    PHARMACOLOGY 152 (8): 1301-1311 DEC 2007
  29. Dowling GJ, Weiss SRB, Condon TP Drugs of abuse and the aging brain NEUROPSYCHOPHARMACOLOGY
    33 (2): 209-218 JAN 2008
  30. Gonzalez R Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance
    NEUROPSYCHOLOGY REVIEW 17 (3): 347-361 SEP 2007
  31. Hayakawa K, Mishima K, Nozako M, et al. Delayed treatment with cannabidiol has a cerebroprotective action via
    a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism JOURNAL OF NEUROCHEMISTRY
    102 (5): 1488-1496 SEP 2007 Times Cited: 0
  32. Parrott AC, Milani RM, Gouzoulis-Mayfrank E, et al. Cannabis and ecstasy/MDMA (3,4-
    methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users
    JOURNAL OF NEURAL TRANSMISSION 114 (8): 959-968 AUG 2007 Times Cited: 0
  33. Jager G, de Win MM, Vervaeke HK, et al. Incidental use of ecstasy: no evidence for harmful effects on cognitive
    brain function in a prospective fMRI study PSYCHOPHARMACOLOGY 193 (3): 403-414 AUG 2007 Times
    Cited: 0
  34. Dagon Y, Avraham Y, Link G, et al. The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice
    and hyperglycemic pheochromocytoma PC12 cells NEUROBIOLOGY OF DISEASE 27 (2): 174-181 AUG
    2007 Times Cited: 0
  35. Sagredo O, Ramos JA, Decio A, et al. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo
    by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A(2A) receptors
    EUROPEAN JOURNAL OF NEUROSCIENCE 26 (4): 843-851 AUG 2007 Times Cited: 0
  36. Esposito G, Scuderi C, Savani C, et al. Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by
    suppressing IL-1 beta and iNOS expression BRITISH JOURNAL OF PHARMACOLOGY 151 (8): 1272-1279
    AUG 2007
  37. Hayakawa K, Mishima K, Nozako M, et al. Repeated treatment with cannabidiol but not Delta(9)
    -tetrahydrocannabinol has a neuroprotective effect without the development of tolerance
    NEUROPHARMACOLOGY 52 (4): 1079-1087 MAR 2007
  38. Garcia-Arencibia M, Gonzalez S, de Lago E, et al. Evaluation of the neuroprotective effect of cannabinoids in a rat
    model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties BRAIN
    RESEARCH 1134 (1): 162-170 FEB 23 2007
  39. da Silva AA, Bester MJ, Pretorius E Effects of Mandrax and Cannabis on the cellular function of chick embryonic
    neurons ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY 23 (1): 82-88 JAN 2007
  40. Pacher P, Batkai S, Kunos G The endocannabinoid system as an emerging target of pharmacotherapy
    PHARMACOLOGICAL REVIEWS 58 (3): 389-462 SEP 2006
  41. Bonfils PK, Reith J, Hasseldam H, et al. Estimation of the hypothermic component in neuroprotection provided by
    cannabinoids following cerebral ischemia NEUROCHEMISTRY INTERNATIONAL 49 (5): 508-518 OCT 2006
  42. Varvel SA, Wiley JL, Yang R, et al. Interactions between THC and cannabidiol in mouse models of cannabinoid
    activity PSYCHOPHARMACOLOGY 186 (2): 226-234 JUN 2006
  43. Zhu HJ, Wang JS, Markowitz JS, et al. Characterization of P-glycoprotein inhibition by major cannabinoids from
    marijuana JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 317 (2): 850-857
    MAY 2006
  44. Parrott AC MDMA in humans: factors which affect the neuropsychobiotogicat profiles of recreational ecstasy users,
    the integrative role of bioenergetic stress JOURNAL OF PSYCHOPHARMACOLOGY 20 (2): 147-163 MAR
    2006
  45. Russo E, Guy GW A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and
    cannabidiol MED HYPOTHESES 66 (2): 234-246 2006
  46. Long LE, Malone DT, Taylor DA The pharmacological actions of cannabidiol DRUG FUTURE 30 (7): 747-753
    JUL 2005
  47. Teare L, Zajicek J The use of cannabinoids in multiple sclerosis EXPERT OPIN INV DRUG 14 (7): 859-869 JUL
    2005
  48. Zhuang SY, Bridges D, Grigorenko E, et al. Cannabinoids produce neuroprotection by reducing intracellular calcium
    release from ryanodine-sensitive stores NEUROPHARMACOLOGY 48 (8): 1086-1096 JUN 2005
  49. Milani RM, Parrott AC, Schifano F, et al. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use
    may compensate for self-rated aggression and somatic symptoms HUM PSYCHOPHARM CLIN 20 (4): 249-261
    JUN 2005
  50. Kovacic P Unifying mechanism for addiction and toxicity of abused drugs with application to dopamine and
    glutamate mediators: Electron transfer and reactive oxygen species MED HYPOTHESES 65 (1): 90-96 2005
  51. Pryce G, Baker D Emerging properties of cannabinoid medicines in management of multiple sclerosis TRENDS
    NEUROSCI 28 (5): 272-276 MAY 2005
  52. Mishima K, Hayakawa K, Abe K, et al. Cannabidiol prevents cerebral infarction via a serotonergic 5-
    hydroxytryptamine(1A) receptor-dependent mechanism STROKE 36 (5): 1071-1076 MAY 2005
  53. Lastres-Becker I, Molina-Holgado F, Ramos JA, et al. Cannabinoids provide neuroprotection against 6-
    hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease NEUROBIOL DIS 19 (1-2): 96-
    107 JUN-JUL 2005
  54. Callaway JC Hempseed as a nutritional resource: An overview EUPHYTICA 140 (1-2): 65-72 2004
  55. Pertwee RG Pharmacological and therapeutic targets for Delta(9)-tetrahydrocannabinol and cannabidiol
    EUPHYTICA 140 (1-2): 73-82 2004
  56. Hayakawa K, Mishima K, Abe K, et al. Cannabidiol prevents infarction via the non-CBI cannabinoid receptor
    mechanism NEUROREPORT 15 (15): 2381-2385 OCT 25 2004
  57. Gonzalez R, Rippeth JD, Carey CL, et al. Neurocognitive performance of methamphetamine users discordant for
    history of marijuana exposure DRUG ALCOHOL DEPEN 76 (2): 181-190 NOV 11 2004
  58. Juttler E, Potrovita I, Tarabin V, et al. The cannabinoid dexanabinol is an inhibitor of the nuclear factor-kappa B
    (NF-kappa B) NEUROPHARMACOLOGY 47 (4): 580-592 SEP 2004
  59. Carter GT, Weydt P, Kyashna-Tocha M, et al. Medicinal cannabis: Rational guidelines for dosing IDRUGS 7 (5):
    464-470 MAY 2004
  60. Biegon A Cannabinoids as neuroprotective agents in traumatic brain injury CURR
    PHARM DESIGN 10 (18): 2177-2183 2004
  61. McQueen DS, Bond SM, Smith PJW, et al. Cannabidiol lacks the vanilloid VR1-mediated vasorespiratory effects
    of capsaicin and anandarnide in anaesthetised rats EUR J PHARMACOL 491 (2-3): 181-189 MAY 3 2004
  62. Tomida I, Pertwee RG, Azuara-Blanco A Cannabinoids and glaucoma BRIT J OPHTHALMOL 88 (5): 708-712
    MAY 1 2004
  63. Geller T, Loftis L, Brink DS Cerebellar infarction in adolescent males associated with acute marijuana use
    PEDIATRICS 113 (4): E365-E370 APR 1 2004
  64. Iuvone T, Esposito G, Esposito R, et al. Neuroprotective effect of cannabidiol, a non-psychoactive component from
    Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells J NEUROCHEM 89 (1): 134-141 APR 2004
  65. Jacintho JD, Kovacic P Neurotransmission and neurotoxicity by nitric oxide, catecholamines, and glutamate: Unifying
    themes of reactive oxygen species and electron transfer CURR MED CHEM 10 (24): 2693-2703 DEC 2003
  66. Massi P, Vaccani A, Ceruti S, et al. Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human
    glioma cell lines J PHARMACOL EXP THER 308 (3): 838-845 MAR 1 2004
  67. Mauler F, Horvath E, De Vry J, et al. BAY 38-7271: A novel highly selective and highly potent cannabinoid
    receptor agonist for the treatment of traumatic brain injury CNS DRUG REV 9 (4): 343-358 WIN 2003
  68. Leker RR, Gai N, Mechoulam R, et al. Drug-induced hypothermia reduces ischemic damage - Effects of the
    cannabinoid HU-210 STROKE 34 (8): 2000-2006 AUG 2003
  69. Braida D, Pegorini S, Arcidiacono MV, et al. Post-ischemic treatment with cannabidiol prevents
    electroencephalographic flattening, hyperlocomotion and neuronal injury in gerbils NEUROSCI LETT 346 (1-2): 61-
    64 JUL 31 2003
  70. Carter GT, Krivickas LS, Weydt P, et al. Drug therapy for amyotrophic lateral sclerosis: Where are we now?
    IDRUGS 6 (2): 147-153 FEB 2003
  71. Baker D, Pryce G, Giovannoni G, et al. The therapeutic potential of cannabis LANCET NEUROL 2 (5): 291-298
    MAY 2003
  72. Russo EB, McPartland JM Cannabis is more than simply Delta(9)-tetrahydrocannabinol
    PSYCHOPHARMACOLOGY 165 (4): 431-432 FEB 2003
  73. Lorenz R A casuistic rationale for the treatment of spastic and myocloni in a childhood neurodegenerative disease:
    Neuronal ceroid lipofuscinosis of the type Jansky-Bielschowsky NEUROENDOCRINOL LETT 23 (5-6): 387-
    390 OCT-DEC 2002
  74. Kimura M, Masuda T, Yamada K, et al. Novel diphenylalkyl piperazine derivatives with dual calcium antagonistic
    and antioxidative activities BIOORG MED CHEM LETT 12 (15): 1947-1950 AUG 5 2002
  75. Mauler F, Mittendorf J, Horvath E, et al. Characterization of the diarylether sulfonylester (-)-(R)-3-(2-
    hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor
    agonist with neuroprotective propertiesJ PHARMACOL EXP THER 302 (1): 359-368 JUL 2002
  76. Downer E, Boland B, Fogarty M, et al.Delta(9)-tetrahydrocannabinol induces the apoptotic pathway in cultured
    cortical neurones via activation of the CB1 receptorNEUROREPORT 12: (18) 3973-3978 DEC 21 2001
  77. Kirkham TC, Williams CM Endogenous cannabinoids and appetite NUTR RES REV 14: (1) 65-86 JUN
    2001

  79. Campbell VA Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome
    c release and caspase-3 activation NEUROPHARMACOLOGY 40: (5) 702-709 APR 2001
  80. Contestabile A Antioxidant strategies for neurodegenerative diseases EXPERT OPIN THER PAT 11: (4) 573-585
    APR 2001
setstats
setstats
setstats